On December 28, 2017, the FDA gave approval for the Dermapace System, a shock wave device intended to be used in the treatment of chronic, full-thickness diabetic foot ulcers. The device uses pulses of energy, similar to sound waves, to mechanically stimulate the wound. Read more.
Related posts
-
Leprosy cases are rising in the US – what is the ancient disease and why is it spreading now?
By Robert A. Schwartz, Rutgers University The word “leprosy”... -
Flesh-eating bacteria infections are on the rise in the US
By Bill Sullivan, Indiana University Flesh-eating bacteria sounds like... -
Rare ‘Flesh-Eating’ Bacterium Spreads North as Oceans Warm
By Christopher O’Donnell, Tampa Bay Times Debbie King barely... -
Silk wound dressing helps eliminate scar tissue formation
Researchers from Huazhong University of Science and Technology, China... -
Predicting diabetic foot ulcer healing improves with thermal imaging
A first of its kind study between RMIT University,... -
Biotech startup announces patent for regenerative tissue therapy
BioLab Sciences, an innovator in regenerative medicine technologies, has...